Elanco Animal Health Incorporated (ELAN)
ELAN moved a median of +0.04% 30 minutes after news, and -0.07% by the close. How ELAN actually reacts to news — the realized, point-in-time move the market made, measured across 1,469 labeled events over the last three years with zero look-ahead.
ELAN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 49% | 1,465 |
| 30-min | +0.04% | 51% | 1,465 |
| 60-min | -0.07% | 47% | 1,465 |
| to close | -0.07% | 46% | 1,468 |
| Middle 50% of ELAN reactions | -0.56% to +0.75% |
|---|---|
| Median reaction (30-min) | +0.04% |
| Measured reactions | 1,469 |
Half of all Elanco Animal Health Incorporated news events land between -0.56% and +0.75% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ELAN reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 33 | +0.83% | 67% | -0.32% |
| Analyst downgrades | 10 | +0.72% | 70% | +2.84% |
| Coverage initiations | 20 | +0.24% | 55% | 0.00% |
| Rating reiterations | 55 | -0.08% | 38% | -0.39% |
| Price-target raises | 30 | +0.05% | 53% | -0.05% |
| Price-target cuts | 14 | -0.15% | 43% | -0.72% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how ELAN ranks against every other measured name →
That’s how ELAN usually reacts — get an email when it moves on news →Email me when ELAN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ELAN's baseline. Nothing else.
Recent ELAN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Elanco to Participate in BofA Securities Global Healthcare Conference 2026 | Press release | PR Newswire | -1.20% | -2.57% | |
| Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care | Press release | PR Newswire | -0.78% | -0.69% | |
| Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement | Press release | PR Newswire | +0.45% | -0.13% | |
| Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference | Press release | PR Newswire | -0.21% | -2.18% | |
| Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility | Press release | PR Newswire | -0.34% | +0.24% | |
| Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species | Press release | PR Newswire | +0.15% | -1.82% | |
| Elanco Animal Health Reports Second Quarter 2026 Results | Press release | PR Newswire | +0.99% | -3.78% | |
| Form 10-Q Elanco Animal Health For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.99% | -3.78% | |
| Form 8-K Elanco Animal Health For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +0.99% | -3.78% | |
| Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs | Press release | PR Newswire | -0.76% | -0.34% | |
| Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablet | Press release | PR Newswire | -0.20% | -0.55% | |
| Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement | Press release | PR Newswire | -1.61% | +1.77% | |
| Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health | Press release | PR Newswire | -0.17% | +1.38% | |
| Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs | Press release | PR Newswire | -0.28% | -2.45% | |
| Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm | Press release | PR Newswire | +2.72% | -1.16% | |
| New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience | Press release | PR Newswire | +1.02% | +4.42% | |
| Form 8-K Elanco Animal Health For: May 21 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +2.44% | |
| Form SD Elanco Animal Health | SEC filing · Form SD | SEC EDGAR | +0.43% | +2.44% | |
| Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market | Press release | PR Newswire | -0.13% | +0.50% | |
| Elanco to Participate in Upcoming Investor Conferences | Press release | PR Newswire | -0.57% | -1.23% | |
| Elanco Animal Health Reports First Quarter 2026 Results | Press release | PR Newswire | +1.45% | +13.23% | |
| Form 10-Q Elanco Animal Health For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.45% | +13.23% | |
| Form 8-K Elanco Animal Health For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +1.45% | +13.23% | |
| Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock | Press release | PR Newswire | +0.90% | -0.81% | |
| Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement | Press release | PR Newswire | +0.09% | -0.39% | |
| Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* | Press release | PR Newswire | +0.09% | +0.09% | |
| Form DEF 14A Elanco Animal Health For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | +0.38% | -0.84% | |
| Form DEFA14A Elanco Animal Health | SEC filing · Form DEFA14A | SEC EDGAR | +0.13% | -1.05% | |
| Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results | Press release | PR Newswire | +3.52% | +9.87% | |
| Form 10-K Elanco Animal Health For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +3.52% | +9.87% | |
| Form 8-K Elanco Animal Health For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | +3.52% | +9.87% | |
| Elanco to Participate in Upcoming Investor Conferences | Press release | PR Newswire | +0.60% | +0.64% | |
| Elanco Announces Updates to Board of Directors | Press release | PR Newswire | +1.25% | +1.13% | |
| Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement | Press release | PR Newswire | -0.38% | +0.08% | |
| Form 8-K Elanco Animal Health For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | -0.42% | +1.49% | |
| Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference | Press release | PR Newswire | +0.65% | +3.12% | |
| Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis | Press release | PR Newswire | +0.24% | -0.20% | |
| Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs | Press release | PR Newswire | +0.11% | -0.94% | |
| Elanco Investor Day Defines New Era as Sustainable Growth Company | Press release | PR Newswire | -0.73% | -6.97% | |
| Form 8-K Elanco Animal Health For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | -0.73% | -6.97% | |
| Elanco executive appointed as Neurizon's Board Observer | Press release | PR Newswire | -0.81% | -1.06% | |
| Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats | Press release | PR Newswire | +0.11% | +0.75% | |
| Elanco to Participate in the Upcoming Investor Conferences | Press release | PR Newswire | +1.13% | -2.08% | |
| Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health | Press release | PR Newswire | +1.37% | — | |
| Elanco Animal Health Reports Third Quarter 2025 Results | Press release | PR Newswire | -0.22% | -4.55% | |
| Form 10-Q Elanco Animal Health For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.22% | -4.55% | |
| Form 8-K Elanco Animal Health For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | -0.22% | -4.55% | |
| Form 8-K Elanco Animal Health For: Oct 31 | SEC filing · Form 8-K | SEC EDGAR | -0.16% | +3.63% | |
| Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species | Press release | PR Newswire | -0.18% | -0.54% | |
| Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs | Press release | PR Newswire | -0.18% | -0.54% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ELAN section they belong to.
Where else ELAN is measured.
ELAN earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AmerisourceBergen Corporation (ABC) | 1,573 | +0.02% | 51% |
| CTI BioPharma Corp. (CTIC) | 1,481 | -0.33% | 39% |
| Centene Corporation (CNC) | 1,456 | +0.01% | 50% |
| Fluidigm Corporation (FLDM) | 1,452 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Elanco Animal Health Incorporated's median reaction calculated?
Every labeled ELAN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,469 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of ELAN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ELAN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.